Sagility India [SAGILITY] vs Sun Pharmaceutical [SUNPHARMA] Detailed Stock Comparison
Sagility India
NSE
Loading...
Sun Pharmaceutical
NSE
Loading...
TLDR: Quick Comparison Summary
Based on 20 vital metrics comparison: Sagility India wins in 6 metrics, Sun Pharmaceutical wins in 11 metrics, with 0 ties. Sun Pharmaceutical appears stronger overall.
View Metrics Details
Vital Metrics Comparison
| Metric | Sagility India | Sun Pharmaceutical | Better |
|---|---|---|---|
| P/E Ratio (TTM) | 31.61 | 37.74 | Sagility India |
| Price-to-Book Ratio | 2.52 | 5.43 | Sagility India |
| Debt-to-Equity Ratio | 16.82 | 3.26 | Sun Pharmaceutical |
| PEG Ratio | N/A | -1.94 | N/A |
| EV/EBITDA | 17.67 | 23.91 | Sagility India |
| Profit Margin (TTM) | 11.31% | 19.29% | Sun Pharmaceutical |
| Operating Margin (TTM) | 14.81% | 24.34% | Sun Pharmaceutical |
| EBITDA Margin (TTM) | 14.81% | 24.34% | Sun Pharmaceutical |
| Return on Equity | 6.47% | 15.08% | Sun Pharmaceutical |
| Return on Assets (TTM) | 4.88% | 11.87% | Sun Pharmaceutical |
| Free Cash Flow (TTM) | $10.90B | $119.44B | Sun Pharmaceutical |
| Dividend Yield | N/A | 1.26% | N/A |
| 1-Year Return | 59.63% | -7.63% | Sagility India |
| Price-to-Sales Ratio (TTM) | 3.57 | 7.29 | Sagility India |
| Enterprise Value | $222.32B | $3,667.83B | Sun Pharmaceutical |
| EV/Revenue Ratio | 3.78 | 6.82 | Sagility India |
| Gross Profit Margin (TTM) | 35.85% | 79.58% | Sun Pharmaceutical |
| Revenue per Share (TTM) | $13 | $224 | Sun Pharmaceutical |
| Earnings per Share (Diluted) | $1.42 | $43.27 | Sun Pharmaceutical |
| Beta (Stock Volatility) | N/A | 0.31 | N/A |
Performance
Key Stats
Valuation
Financials
Short Interest
Dividends
Sagility India vs Sun Pharmaceutical Stock Performance Analysis
Loading Price Chart...
Performance Comparison
Short-term Returns
| Stock | 1D | 1W | 1M | 3M | 6M | YTD |
|---|---|---|---|---|---|---|
| Sagility India | 1.21% | 2.41% | 3.65% | 2.76% | -0.53% | -5.15% |
| Sun Pharmaceutical | 0.10% | 0.07% | -2.94% | -5.16% | -0.08% | -13.09% |
Long-term Returns
| Stock | 1Y | 3Y | 5Y | 10Y | 15Y | 20Y |
|---|---|---|---|---|---|---|
| Sagility India | 59.63% | 59.63% | 59.63% | 59.63% | 59.63% | 59.63% |
| Sun Pharmaceutical | -7.63% | 86.35% | 195.13% | 85.03% | 824.99% | 2,689.93% |
Performance & Financial Health Analysis: Sagility India vs Sun Pharmaceutical
| Metric | SAGILITY | SUNPHARMA |
|---|---|---|
| Market Information | ||
| Market Cap | ₹210.14B | ₹3.92T |
| Market Cap Category | Large cap | Large cap |
| 10 Day Avg. Volume | 26,422,162 | 2,090,629 |
| 90 Day Avg. Volume | 36,040,895 | 2,138,036 |
| Last Close | ₹46.06 | ₹1,641.80 |
| 52 Week Range | ₹27.02 - ₹56.40 | ₹1,553.05 - ₹1,960.35 |
| % from 52W High | -18.33% | -16.25% |
| All-Time High | ₹56.40 (Dec 30, 2024) | ₹1,960.35 (Sep 30, 2024) |
| % from All-Time High | -18.33% | -16.25% |
| Growth Metrics | ||
| Quarterly Revenue Growth | 0.26% | 0.10% |
| Quarterly Earnings Growth | 5.66% | -0.20% |
| Financial Health | ||
| Profit Margin (TTM) | 0.11% | 0.19% |
| Operating Margin (TTM) | 0.15% | 0.24% |
| Return on Equity (TTM) | 0.06% | 0.15% |
| Debt to Equity (MRQ) | 16.82 | 3.26 |
| Cash & Liquidity | ||
| Book Value per Share (MRQ) | ₹17.81 | ₹300.99 |
| Cash per Share (MRQ) | ₹0.73 | ₹108.88 |
| Operating Cash Flow (TTM) | ₹9.67B | ₹110.84B |
| Levered Free Cash Flow (TTM) | ₹5.39B | ₹109.29B |
| Dividends | ||
| Last 12-Month Dividend Yield | N/A | 1.26% |
| Last 12-Month Dividend | N/A | ₹21.00 |
Valuation & Enterprise Metrics Analysis: Sagility India vs Sun Pharmaceutical
| Metric | SAGILITY | SUNPHARMA |
|---|---|---|
| Price Ratios | ||
| P/E Ratio (TTM) | 31.61 | 37.74 |
| Forward P/E | 21.83 | 49.97 |
| PEG Ratio | N/A | -1.94 |
| Price to Sales (TTM) | 3.57 | 7.29 |
| Price to Book (MRQ) | 2.52 | 5.43 |
| Market Capitalization | ||
| Market Capitalization | ₹210.14B | ₹3.92T |
| Enterprise Value | ₹222.32B | ₹3.67T |
| Enterprise Value Metrics | ||
| Enterprise to Revenue | 3.78 | 6.82 |
| Enterprise to EBITDA | 17.67 | 23.91 |
| Risk & Other Metrics | ||
| Beta | N/A | 0.31 |
| Book Value per Share (MRQ) | ₹17.81 | ₹300.99 |
Financial Statements Comparison: Sagility India vs Sun Pharmaceutical
Financial Metrics
Loading Financial Charts...
Revenue
EBITDA
Operating Margin
Free Cash Flow
Long Term Debt
Profit Margin
Current Ratio
Operating Cash Flow
Income Statement (MRQ)
| Metric (MRQ) | SAGILITY | SUNPHARMA |
|---|---|---|
| Revenue/Sales | ₹15.39B | ₹137.86B |
| Cost of Goods Sold | ₹9.87B | ₹28.15B |
| Gross Profit | ₹5.52B | ₹109.71B |
| Research & Development | N/A | N/A |
| Operating Income (EBIT) | ₹2.28B | ₹33.72B |
| EBITDA | ₹3.56B | ₹47.66B |
| Pre-Tax Income | ₹2.10B | ₹31.73B |
| Income Tax | ₹618.28M | ₹8.70B |
| Net Income (Profit) | ₹1.49B | ₹22.93B |
Balance Sheet & Liquidity Metrics (MRQ)
| Metric (MRQ) | SAGILITY | SUNPHARMA |
|---|---|---|
| Cash & Equivalents | ₹3.44B | ₹102.69B |
| Total Current Assets | ₹18.21B | ₹526.24B |
| Total Current Liabilities | ₹10.89B | ₹181.94B |
| Long-Term Debt | ₹10.23B | ₹3.58B |
| Total Shareholders Equity | ₹83.36B | ₹724.86B |
| Retained Earnings | ₹8.83B | ₹578.62B |
| Property, Plant & Equipment | ₹9.22B | ₹100.36B |
Cash Flow Statement Comparison (MRQ)
| Metric (MRQ) | SAGILITY | SUNPHARMA |
|---|---|---|
| Operating Cash Flow | ₹2.75B | N/A |
| Capital Expenditures | ₹-253.46M | N/A |
| Free Cash Flow | ₹3.43B | N/A |
| Debt Repayment | ₹-2.43B | N/A |
| Common Stock Repurchase | N/A | N/A |
Short Interest & Institutional Ownership Analysis
| Metric | SAGILITY | SUNPHARMA |
|---|---|---|
| Shares Short | N/A | N/A |
| Short Ratio | N/A | N/A |
| Short % of Float | N/A | N/A |
| Average Daily Volume (10 Day) | 26,422,162 | 2,090,629 |
| Average Daily Volume (90 Day) | 36,040,895 | 2,138,036 |
| Shares Outstanding | 4.68B | 2.40B |
| Float Shares | 1.53B | 1.04B |
| % Held by Insiders | 0.67% | 0.56% |
| % Held by Institutions | 0.10% | 0.25% |
Dividend Analysis & Yield Comparison: Sagility India vs Sun Pharmaceutical
| Metric | SAGILITY | SUNPHARMA |
|---|---|---|
| Last 12-Month Dividend | N/A | ₹21.00 |
| Last 12-Month Dividend Yield | N/A | 1.26% |
| 3-Year Avg Annual Dividend | N/A | ₹14.67 |
| 3-Year Avg Dividend Yield | N/A | 0.46% |
| 3-Year Total Dividends | N/A | ₹44.00 |
| Ex-Dividend Date | N/A | Jul 07, 2025 |